Associations of novel adipocytokines with bone biomarkers in intra uterine growth-restricted fetuses/neonates at term

References

• Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocrine Rev 1997;18:832–72
   PubMed Web of Science ®Google Scholar
• Beltrand J, Alison M, Nicolescu R, et al. Bone mineral content at birth is determined both by birth weight and fetal growth pattern. Pediatr Res 2008;64:86–90
   PubMed Web of Science ®Google Scholar
• Fitzhardinge PM, Steven EM. The small-for-date infant. I. Later growth patterns. Pediatrics 1972;49:671–81
   Google Scholar
• Cooper C, Javaid MK, Taylor P, et al. The fetal origins of osteoporotic fracture. Calcif Tissue Int 2002;70:391–4
   PubMed Web of Science ®Google Scholar
• Magni P, Dozio E, Galliera E, et al. Molecular aspects of adipokine-bone interactions. Curr Mol Med 2010;10:522–32
   PubMedGoogle Scholar
• Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol 2009;160:337–47
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. The role of adipocytokines in fetal growth. Ann N Y Acad Sci 2010;1205:82–7
   PubMed Web of Science ®Google Scholar
• Alexe DM, Syridou G, Petridou ET. Determinants of early life leptin levels and later life degenerative outcomes. Clin Med Res 2006;4:326–35
   PubMedGoogle Scholar
• Briana DD, Boutsikou M, Baka S, et al. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 2008;93:153–7
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, et al. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr 2007;96:1751–4
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007;119:e1314–18
   PubMed Web of Science ®Google Scholar
• Briana DD, Gourgiotis D, Boutsikou M, et al. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction. Bone 2008;42:307–13
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, et al. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term: the impact of intrauterine growth restriction. Neonatology 2009;96:132–6
   PubMedGoogle Scholar
• Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet 1992;339:283–7
   PubMed Web of Science ®Google Scholar
• Burkhardt T, Schaffer L, Schneider C, et al. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol 2006;128:248–52
   PubMed Web of Science ®Google Scholar
• Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol 2012;39:769–83
   PubMedGoogle Scholar
• Kovacs CS. Bone development in the fetus and neonate: role of the calciotropic hormones. Curr Osteoporos Rep 2011;9:274–83
   PubMedGoogle Scholar
• Chen H, Miller S, Lane RH, et al. Intrauterine growth restriction decreases endochondral ossification and bone strength in female rats. Am J Perinatol 2013;30:261–6
   PubMedGoogle Scholar
• Holroyd CR, Harvey NC, Crozier SR, et al. Placental size at 19 weeks predicts offspring bone mass at birth: findings from the Southampton Women’s Survey. Placenta 2012;33:623–9
   PubMedGoogle Scholar
• Javaid MK, Godfrey KM, Taylor P, et al. Umbilical cord leptin predicts neonatal bone mass. Calcif Tissue Int 2005;76:341–7
   PubMedGoogle Scholar
• Bar-El Dadon S, Shahar R, Katalan V, et al. Leptin administration affects growth and skeletal development in a rat intrauterine growth restriction model: preliminary study. Nutrition 2011;27:973–7
   PubMed Web of Science ®Google Scholar
• Biver E, Salliot C, Combescure C, et al. Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:2703–13
   PubMed Web of Science ®Google Scholar
• Thommesen L, Stunes AK, Monjo M, et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006;99:824–34
   PubMed Web of Science ®Google Scholar
• Oh KW, Lee WY, Rhee EJ, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005;63:131–8
   PubMed Web of Science ®Google Scholar
• Xie H, Tang SY, Luo XH, et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007;80:201–10
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Iorio M, Napoli N, et al. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. J Endocrinol Invest 2011;34:e12–5
   PubMed Web of Science ®Google Scholar
• Xie H, Yuan LQ, Luo XH, et al. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 2007;12:247–54
   PubMedGoogle Scholar
• Hu PF, Chen WP, Tang JL, et al. Apelin plays a catabolic role on articular cartilage: in vivo and in vitro studies. Int J Mol Med 2010;26:357–63
   PubMedGoogle Scholar
• Peng XD, Xie H, Zhao Q, et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008;387:31–5
   PubMed Web of Science ®Google Scholar
• Zhang H, Xie H, Zhao Q, et al. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. J Endocrinol Invest 2010;33:707–11
   PubMed Web of Science ®Google Scholar